Bright Minds Biosciences Inc has split its stock once since its initial public offering (IPO). The stock split of Bright Minds Biosciences Inc occurred on July 14, 2023 on a 1-for-5 basis, meaning that for 5 shares of DRUG owned pre-split, shareholders then owned 1 share.
This action has increased the stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that a stock split only changes the number of shares and the price per share with no impact on Bright Minds Biosciences Inc's total market capitalization.
The answer will depend on the decisions of the company's managers and market volatility. Bright Minds Biosciences Inc has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when DRUG stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Bright Minds Biosciences Inc's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.
